Editors' ChoiceVaccines

A vaccine to kiss EBV goodbye

See allHide authors and affiliations

Science Translational Medicine  24 Apr 2019:
Vol. 11, Issue 489, eaax1729
DOI: 10.1126/scitranslmed.aax1729


A nanoparticle Epstein-Barr virus glycoprotein gH/gL vaccine elicits antibodies that mediate cell type–independent protection from infection.

View Full Text

Stay Connected to Science Translational Medicine